The purpose of the report is to illustrate the state of the market of Drug Delivery Technologies, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.
Browse here for full report with Toc: https://www.credenceresearch.com/report/drug-delivery-technologies-market
Patent expiry of several major drugs, coupled with the expensive business of development of new chemical entity has posed as a prime concern for pharmaceutical manufacturers. Development of new chemical entity is often observed to be a more expensive affair than development of novel delivery technology. Hence, several pharmaceutical manufacturers have adopted new drug delivery technologies for their portfolio as an effective life cycle management strategy.
The global drug delivery devices market is studied for mode of administration and geography segmentations. Oral, pulmonary, transdermal, injectable, nasal, implantable, and ocular, buccal etc. cumulatively make the drug delivery technologies market. Among these, oral drug delivery is the largest segment, followed by pulmonary drug delivery in 2015 at a combined market share of over 65%.
Merck, 3M Company, Johnson and Johnson, Becton Diskinson and Company and others are some of the major players in the global drug delivery technologies market.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Drug Delivery Technologies buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Drug Delivery Technologies contains:
Analysis and forecast of Drug Delivery Technologies market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Drug Delivery Technologies market;
Assessment and forecast of Drug Delivery Technologies market development;
Financial and business profiles of the leading companies in the Drug Delivery Technologies industry.
Also you can request us for sample in PDF with depth details and graph: https://www.credenceresearch.com/sample-request/57779
– Up to date working Drug Delivery Technologies data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Drug Delivery Technologies for the period 2018 to 2026
– Planned Drug Delivery Technologies additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Drug Delivery Technologies projects by region, key countries, and companies
– Details of major planned Drug Delivery Technologies projects in the world up to 2026
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Credence Research Inc.
105 N 1st ST #429
Toll Free (US/CANADA): +1-800-361-8290